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Mycobacterium tuberculosis is able to use a variety of carbon sources in vivo and current
knowledge suggests that cholesterol is used as a carbon source during infection. The catabolized
cholesterol is used both as an energy source (ATP generation) and as a source of precursor
molecules for the synthesis of complex methyl-branched fatty acids. In previous studies, we
described a TetR-type transcriptional repressor, kstR, that controls the expression of a number of
genes involved in cholesterol catabolism. In this study, we describe a second TetR-type repressor,
which we call kstR2. We knocked this gene out in Mycobacterium smegmatis and used
microarrays and quantitative RT-PCR to examine the effects on gene expression. We identified
a palindromic regulatory motif for KstR2, showed that this motif is present in three promoter
regions in mycobacteria and rhodococcus, and demonstrated binding of purified KstR2 to the
motif. Using a combination of motif location analysis, gene expression analysis and the
examination of gene conservation, we suggest that kstR2 controls the expression of a 15 gene
regulon. Like kstR, kstR2 and the kstR2 regulon are highly conserved among the actinomycetes
and studies in rhodococcus suggest a role for these genes in cholesterol catabolism. The
functional significance of the regulon and implications for the control of cholesterol utilization are
discussed.
INTRODUCTION
The success of Mycobacterium tuberculosis, the causative
agent of tuberculosis, is partly attributed to its ability to
persist within the host (Honer zu Bentrup & Russell, 2001).
The antibiotic insensitivity shown by persistent bacilli
makes the understanding of the intracellular lifestyle of this
pathogen a matter of urgency (Sacchettini et al., 2008). A
major advance in understanding the pathogenicity of M.
tuberculosis was the discovery that the bacterium uses lipids
as a carbon source in vivo. Evidence for this is based on
observations that enzymes involved in fatty acid degrada-
tion are induced during infection (Dubnau et al., 2002,
2005; Schnappinger et al., 2003; Tailleux et al., 2008; Talaat
et al., 2004) and deletion of genes involved in fatty acid
metabolism causes severe attenuation in disease models
(McKinney et al., 2000; Munoz-Elias & McKinney, 2005;
Munoz-Elias et al., 2006; Sassetti & Rubin, 2003). Despite
the body of evidence for the use of lipids as a carbon source
during infection, the nature of the lipid(s) utilized has
remained elusive and little is known about the genetic
regulation of lipid metabolism in mycobacteria.
Recently, we described a transcriptional repressor, kstR,
that controls the expression of a large regulon involved in
lipid metabolism in mycobacteria (Kendall et al., 2007). A
study undertaken in the closely related species, Rhodococcus
jostii RHA1, showed that many of the genes in the kstR
regulon are induced by the steroid cholesterol and the
authors of this study assigned a number of genes in the
regulon to the cholesterol degradation pathway (Van der
Geize et al., 2007). Subsequent biochemical and structural
Abbreviations: EMSA, electrophoretic mobility shift assays; OADC, oleic
acid–albumin–dextrose–catalase; RTq-PCR, quantitative RT-PCR.
Fully annotated microarray data have been deposited in BmG@Sbase
(accession number E-BUGS-99; http://bugs.sgul.ac.uk/E-BUGS-99)
and also ArrayExpress (accession number E-BUGS-99).
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cholesterol catabolism (Capyk et al., 2009; Knol et al., 2008;
Lack et al., 2009; Yam et al., 2009). The observation that
many of the genes in the kstR regulon are also induced in
vivo or are essential for virulence highlights the importance
of cholesterol catabolism in the pathogenicity of M.
tuberculosis (Brzostek et al., 2007; Chang et al., 2007; Hu
et al., 2010; Nesbitt et al., 2010; Rengarajan et al., 2005;
Sassetti & Rubin, 2003; Schnappinger et al., 2003; Yam
et al., 2009).
The study by Van der Geize et al. (2007) identified six
clusters of genes that were upregulated in response to
cholesterol in R. jostii. One of these clusters corresponds to
the kstR regulon. In this study, we describe a second
transcriptional repressor, Rv3557c (kstR2), that controls the
expression of a subset of genes within the kstR cluster. This
work further informs how the genes involved in cholesterol
catabolism are controlled in mycobacteria and related
actinomycetes. The observation that a number of genes in
the kstR2 regulon are induced in macrophages or are
essential for infection (Rengarajan et al., 2005; Sassetti &
Rubin, 2003; Schnappinger et al., 2003) means that this
work also informs the regulatory networks utilized by
mycobacteria and other pathogenic actinomycetes for
survival in vivo.
METHODS
Bacterial strains and culture conditions. The strains and plasmids
used in this study are described in Table 1. All bacterial cultures were
grown at 37 uC and liquid cultures were grown with shaking
(200 r.p.m.). Escherichia coli DH5a was used as a strain for cloning
and E. coli BL21 (DE3) was used as a host for expression. Both E. coli
strains were grown in Luria–Bertani medium. Mycobacterium
smegmatis mc
2155 was grown in Middlebrook 7H9 broth (Difco)
containing 10% oleic acid–albumin–dextrose–catalase supplement
(OADC; Becton Dickinson) and 0.05% Tween 80 or Middlebrook
7H11 agar containing 10% OADC. Hygromycin (50 mgml
21),
kanamycin (50 mgml
21 for E. coli and 20 mgm l
21 for M. smegmatis),
5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (Xgal, 50 mgml
21)
and sucrose (2% w/v) were used for selection as appropriate.
Deletion of kstR2Msm. A 505 bp deletion was made in kstR2Msm by
homologous recombination (Parish et al., 1999). Briefly, a 3.5 kb
fragment was amplified from genomic DNA using DkstR2Msm forward
and reverse primers (Table 2) and cloned into pUC18 using the KpnI
sites designedwithintheprimers.Theresultingplasmid,pPB1,wasused
as a template in an inverse PCR with inv_kstR2Msm forward and reverse
primers. EcoRV digestion and religation of the resulting PCR fragment
created plasmid pPB2 containing the 505 bp deletion in kstR2Msm.
Finally, a 3 kb fragment containing DkstR2Msm was subcloned from
pPB2 into p2NIL (pPB3) and the PacI cassette from pGOAL19 was
inserted into pPB3 resulting in the suicide delivery vector pPB4.
pPB4 was electroporated into M. smegmatis mc
2155 and single
crossovers were selected for using kanamycin, hygromycin and Xgal.
A single antibiotic-resistant blue colony was taken and restreaked
onto 7H11 with no selection and allowed to grow for 3–5 days.
Double crossovers were selected for by plating serial dilutions onto
7H11 plates containing Xgal and sucrose. Potential double crossovers
(white sucrose-resistant colonies) were screened using colony PCR.
The resulting mutant was called DkstR2Msm. The procedure was
repeated in a DkstRMsm background to make a DkstR/DkstR2 double
mutant. The whole mutagenesis and selection procedure is not
affected by the DkstRMsm background as this is an unmarked mutant.
RNA extraction. RNA extractions were done by direct sampling into
guanidinium thiocyanate (GTC). A 10 ml volume of an exponential
culture (OD600 0.4–0.5) was added to 40 ml 5 M GTC. The culture was
pelleted by centrifugation (20 min, 4000 g,4uC) and resuspended in
200 ml water. A 700 ml volume of buffer RLT (Qiagen) wasadded to the
resuspended pellet and the bacteria were lysed in screw-capped tubes
containing 0.5 ml 0.1 mm zirconia/silica beads (Biospec) using a
Precellys system (Stretton Scientific). Cell lysates were recovered by
centrifugation (5 min, 13000 g,4uC) and RNA purified from the
lysate using an RNeasy kit (Qiagen) according to the manufacturer’s
Table 1. Bacterial strains and plasmids used in this study
Strain/plasmid Genotype/description Source/reference
Strains
E. coli
DH5a supE44 DlacU169 (wlacZDM15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1 Invitrogen
BL21(DE3) ompT hsdSB(r{
B m{
B ) gal dcm (DE3) Novagen
M. smegmatis
mc
2155 High-frequency transformation mutant ATCC 607 Snapper et al. (1990)
DkstR2Msm DkstR2Msm This study
Plasmids
p2NIL Gene manipulation vector, Kan Parish & Stoker (2000)
pGOAL19 PacI cassette vector, hyg Pag85–lacZ Phsp60–sacB Amp Parish & Stoker (2000)
pET30a E. coli expression vector, Kan Novagen
pUC18 E. coli cloning vector, Amp Sambrook & Russell (2001)
pPB1 3.5 kb fragment containing kstR2Msm in pUC18, Amp This study
pPB2 505 bp deletion of kstR2Msm in pPB2, Amp This study
pPB3 3.0 kb fragment containing DkstR2Msm in p2NIL, Kan This study
pPB4 pPB3 with the pGOAL19 cassette inserted, Kan, Hyg This study
pSK49 kstR2Mtb in pET30a expression vector, Kan This study
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http://mic.sgmjournals.org 1363instructions. A DNase treatment was done ‘on the column’ according
to the manufacturer’s instructions and the samples were eluted in 30 ml
RNase-free water. Finally, the quality and quantity of the RNA was
assessed using a NanoDrop (NanoDrop technologies).
Reverse transcription reactions for quantitative RT-PCR (RTq-
PCR). RNA was given a second round of DNase treatment
(Invitrogen) for 30 min at 37 uC prior to reverse transcription.
RNA (100 ng) was reverse transcribed in a total volume of 20 ml with
300 ng random primers (Invitrogen), 10 mM DTT, 0.5 mM each of
dCTP, dATP, dGTP and dTTP, and 200 units Superscript III reverse
transcriptase (Invitrogen). Primers were annealed by heating to 65 uC
for 10 min and then snap-cooled on ice before adding the remaining
components. Reverse transcription took place at 55 uC for 50 min.
RTq-PCR. RTq-PCRs were done using the DyNAmo SYBR Green
qPCR kit (MJ Research) and performed using the DNA Engine
Opticon 2 System (GRI). A 1 ml volume (equivalent to 5 ng RNA) of
cDNA was used in the reactions which also contained 16 DNA
master mix, 0.3 mM of each primer in a total reaction volume of
20 ml. The sequences of the primers used are given in Table 2.
Reactions were heated to 95 uC for 10 min before cycling for 35 cycles
of 95 uC for 30 s, 62 uC for 20 s, and 72 uC for 20 s. An 80 uC melt
was done at the end of each cycle to ensure that primer dimers had
melted before fluorescence due to PCR product was captured. The
specificity of the PCR product was ensured by doing melting curve
analysis and running the fragment on a gel at the end of each PCR.
The experiment was performed in triplicate and each gene was
measured in duplicate, giving a total of six data points per gene.
Expression and purification of recombinant KstR2Mtb. The
kstR2Mtb gene was cloned into the pET30a expression vector using
NcoI and HindIII sites. The resulting plasmid, pSK49, was sequence
verified and used for expression and purification of C-terminally His-
tagged KstR2Mtb. For expression, E. coli BL21(DE3) cultures contain-
ing plasmid pSK49 were grown at 37 uC until mid-exponential phase.
Cultures were induced with 1 mM IPTG for 2 h at 37 uC and
harvested by centrifugation (10 min, 4000 g,4uC). The cell pellet was
resuspended in 5 ml lysis buffer (20 mM HEPES pH 8.0, 150 mM
NaCl, 1 mM b-mercaptoethanol, 10 mM imidazole) and lysed by
passage through a cell disrupter (Constant Systems) set at 18000 p.s.i.
(124.2 MPa). The lysate was centrifuged (25 min, 16000 g,4uC) and
His6-KstR2Mtb from the soluble fraction was purified by immobilized
metal ion affinity chromatography using a HiTrap Ni-NTA column
(GE Healthcare Biosciences), followed by size exclusion chromato-
graphy using a Superdex 200 10/30 column (GE Healthcare
Biosciences).
Electrophoretic mobility shift assays (EMSAs). Untagged recom-
binant KstR2Mtb was used in EMSAs. The tag was removed by
cleavage with recombinant tobacco etch virus protease. Single-
stranded oligonucleotide probes (30-mer) were annealed in shift
buffer, consisting of 20 mM Tris/HCl (pH 8.0), 10 mM MgCl2 and
75 mM NaCl by heating to 95 uC for 10 min and cooling slowly to
room temperature. The resulting double-stranded oligonucleotide
probes were incubated at a final concentration of 1 mM for 20 min at
37 uC with recombinant KstR2Mtb at a final concentration of 6 mM.
Reaction mixtures were loaded onto an 8% polyacrylamide gel in
0.56 TBE buffer (45 mM Tris-borate, 1 mM EDTA). After
electrophoresis, gels were stained for 1 h at room temperature in
0.56 TBE buffer with 0.04 mg ethidium bromide ml
21.
For the competition experiments, the double-stranded oligonucleo-
tide probes were end-labelled with DIG-11-ddUTP using the DIG gel
shift kit, second generation (Roche), according to the manufacturer’s
instructions. For the binding reaction, 0.03 pmol labelled probe in
shift buffer, with the addition of 0.1 mg poly-L-lysine and 1 mg
poly[d(I-C)] ml
21, was incubated with 3 pmol of recombinant
KstR2Mtb. Specific and non-specific competitors were added for the
control reactions. Specific competition reaction mixtures contained a
150-fold excess of unlabelled probe, and non-specific competion
mixtures contained an excess of poly[d(I-C)]. Incubations were carried
out for 20 min at 37 uC, and reaction mixtures were loaded onto 8%
polyacrylamide gels in 0.56 TBE buffer. After electrophoresis, the
DNA–protein complexes were contact blotted onto positively charged
Table 2. Primers used in this study
Primer Orientation Sequence* Purpose
DkstR2Msm Forward CCGGTACCGGCATCGGCTCGACCA Cloning kstRMsm into pUC18
Reverse CCGGTACCGTCAGAAAGCTTTCATCACGCG Cloning kstRMsm into pUC18
inv_kstR2Msm Forward GGGATATCCAGCAGTACCTCGCCATCGTT Making kstRMsm deletion
Reverse GGGATATCAGCAGCTCATCGCGTCTGCTAGC Making kstRMsm deletion
pET_kstR2Mtb Forward AGTCCATGGGGATGGATCGAGTG Cloning kstR2Mtb into pET30a for expression
Reverse CGGAAGCTTTCAGACTCCCTCTTT Cloning kstR2Mtb into pET30a for expression
MSMEG_6001 Forward CTCGGTCACCGTGAACTACC RTq-PCR expression analysis
Reverse TCTGCATCTCCTTGATCTGTCG RTq-PCR expression analysis
MSMEG_6038 Forward TCGATGAGATCGGCTTCTTC RTq-PCR expression analysis
Reverse CAGTTGTGCACACCGATGAT RTq-PCR expression analysis
MSMEG_2758 (sigA) Forward CCAAGGGCTACAAGTTCTCG RTq-PCR expression analysis
Reverse CTTGTTGATCACCTCGACCA RTq-PCR expression analysis
Rv3549c/Rv3550 Forward GCGTACCAAGCAAGTGCTTGCTTAGGTAGC Oligonucleotides used in EMSAs
Reverse GCTACCTAAGCAAGCACTTGCTTGGTACGC Oligonucleotides used in EMSAs
Rv3557c/Rv3558 Forward GCTGGCCGAGCAAGCGCTTGGTTGATAGTC Oligonucleotides used in EMSAs
Reverse GACTATCAACCAAGCGCTTGCTCGGCCAGC Oligonucleotides used in EMSAs
Rv3560c/Rv3561 Forward GCTAACCTACCAAGCACTTGCTTTGTTAGG Oligonucleotides used in EMSAs
Reverse CCTAACAAAGCAAGTGCTTGGTAGGTTAGC Oligonucleotides used in EMSAs
*The locations of the motifs are underlined; bold type indicates the start (ATG) and stop (TCA) codons of the kstR2 gene.
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DIG-alkaline phosphatase and the chemiluminescent substrate CSPD,
asdescribedby themanufacturer (Roche). Membraneswereexposedto
X-ray film at room temperature for 10–30 min.
Microarray analysis of M. smegmatis DkstR2. Microarrays were
provided by the Pathogen Functional Genomics Resource Centre at
TIGR (http://pfgrc.jcvi.org/). Wild-type RNA was hybridized against
mutant RNA and the experiments were performed with biological
triplicates and technical replicates that included a dye-swap. The
labelling and hybridizations were performed as described previously
(Kendall et al., 2007). Briefly, 2–10 mg RNA was labelled with either
Cy3-dCTP or Cy5-dCTP (Amersham Pharmacia Biotech) in a
reaction containing 3 mg random primers, 0.5 mM each of dATP,
dGTP and dTTP, 0.2 mM dCTP, 10 mM DTT, 60 mmol Cy3-dCTP
(or Cy5-dCTP) and 500 units Superscript II (Invitrogen Life
Technologies). Samples were purified using a MinElute PCR
Purification kit from Qiagen and hybridized onto the array in
hybridization buffer (46 SSC, 40% formamide, 0.1% SDS).
Hybridization took place at 65 uC for 16 h and slides were washed
in a series of buffers (Buffer 1: 16 SSC, 0.05% SDS, 65 uC; Buffer 2:
0.066 SSC, room temperature). Finally slides were dried by
centrifugation (1500 g, 5 min, room temperature) and scanned
(Affymetrix 418 scanner).
Microarray data analysis. Data analysis was performed using
functions from the BmG@Sbase microarray data analysis pipeline
(http://www.bugs.sghms.ac.uk/bugsbase/), limma (linear models for
microarray data analysis) (Smyth et al., 2005; http://bioinf.wehi.edu.
au/limma/) and yasma (Wernisch et al., 2003) software packages.
Data for duplicate spots within the arrays were averaged before the
linear model fit was performed. False discovery rate adjustment was
made (Benjamini, 1995) and genes were considered significant if they
had an adjusted P-value less than 0.05.
Bioinformatic analyses. Comparative genomics and genome
browsing were performed using ACT (Carver et al., 2005). Sequence
similarity searches were performed using BLAST (Ladunga, 2002).
Sequence alignments were performed using CLUSTAL W (Thompson
et al., 1994) andmotif analysiswascarried out usingMEME andMAST
(Bailey & Elkan, 1994; Bailey & Gribskov, 1998).
RESULTS
Comparative genomics of the kstR2 region in
M. smegmatis, M. tuberculosis and R. jostii
In M. smegmatis, kstR controls the expression of 83 genes
(Kendall et al., 2007). Fifty-five of these kstR-controlled
genes lie within a particular region in the M. smegmatis
genome (MSMEG_5893–MSMEG_6043) (Fig. 1a). This
region is highly conserved in M. tuberculosis (Rv3492c–
Rv3574) and R. jostii (ro4482–ro04705), and studies in R.
jostii have shown that all of the kstR-controlled genes
within the ro4482–ro04705 region are induced by choles-
terol (Van der Geize et al., 2007). However, not all of the
cholesterol-induced genes in this region are controlled by
kstR. Analysis of the R. jostii genome shows that there are
three possible operons (ro04654–ro04649, ro04599–ro04598
and ro04597–ro04591) that are induced by cholesterol but
not controlled by kstR (Fig. 1b, bottom line). These genes
are conserved in M. tuberculosis (Rv3548c–Rv3565, Fig. 1b,
middle line) and M. smegmatis (MSMEG_5999–
MSMEG_6017, Fig. 1b, top line), and examination of the
function of the genes in this region shows that there is
another TetR-type regulator which we are calling kstR2
(ro04598, Rv3557c, MSMEG_6009).
Given that these genes are induced by cholesterol in R.
jostii, but are not part of the kstR regulon, and that genes
are often controlled by regulators in the near vicinity, we
hypothesized that kstR2 controls the expression of genes
within this cluster. In order to test this, we searched for
possible regulatory motifs firstly within its own promoter
region, and then on a genome-wide scale.
Identification of a potential KstR2 regulatory
binding motif
Examination of the genomes of other closely related
actinomycetes (Mycobacterium avium subsp. paratubercu-
losis, Mycobacterium avium, Mycobacterium marinum,
Nocardia farcinica and Rhodococcus equi) using ACT and
CLUSTAL W showed that kstR2 is conserved in these species
with all orthologues showing over 50% amino acid identity
to the M. tuberculosis protein (data not shown). In order to
identify a potential regulatory motif for KstR2, we used the
promoter regions of the kstR2 orthologues as a training set
for the motif identification program MEME (Bailey &
Elkan, 1994). This identified a potential regulatory
sequence that contains a 14 bp inverted palindromic motif
AnCAAGnnCTTGnT (Fig. 2). Palindromic DNA binding
regions are a common feature of TetR-type regulators and
this motif is similar in structure to the KstR motif, which is
also a 14 bp inverted palindrome. In order to determine
if the motif is present elsewhere in the genomes of
M. tuberculosis, M. smegmatis and R. jostii, we searched a
database of intergenic regions using MAST (Bailey &
Gribskov, 1998). This predicted three motifs in each
genome that were all situated within the intergenic regions
of divergently transcribed genes near to kstR2, and are
shown in Fig. 1 and Table 3.
KstR2Mtb binds to the conserved regulatory motif
In order to determine whether KstR2 binds directly to the
motif that was identified, the protein from M. tuberculosis
(KstR2Mtb) was expressed, purified and used in EMSAs.
Probes (30 bp) from the three intergenic regions (Rv3549c–
Rv3550, Rv3557c–Rv3558 and Rv3560c–Rv3561) containing
the motif sequences were used in the assay (Table 2, the
locations of the motifs are underlined); the results are
shown in Fig. 3. The presence of the purified protein clearly
retarded the movement of all the 30 bp probes through the
gel, indicating binding of the KstR2Mtb protein to the
motifs in each of the regions (Fig. 3a). In order to
determine whether the binding was specific, competition
assays were used with non-specific and specific competitors
(Fig. 3b). The binding was prevented by adding a 150-fold
excess of unlabelled probe (Fig. 3b, lane 2) but was not
altered by the addition of the non-specific inhibitor
Regulation of cholesterol metabolism in mycobacteria
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experiments clearly show that purified KstR2Mtb binds
specifically to the motif within the three intergenic regions.
Expression analysis of DkstR2Msm and defining
the kstR2 regulon
In order to identify the genes controlled by kstR2, a 505 bp
deletion of kstR2 was made in the M. smegmatis genome
using homologous recombination (Parish et al., 1999). The
mutagenesis was verified by PCR and sequencing as
described in Methods (data not shown). Microarrays were
used to determine the effects of knocking out kstR2Msm on
gene expression. RNA from wild-type and mutant bacteria
was labelled with Cy dyes and competitively hybridized
onto oligonucleotide arrays. The results are shown in
Table 4. Using a P-value cut-off of 0.05, a total of eight
genes were significantly upregulated and three genes were
downregulated (Table 4). All of the significantly upregu-
lated genes were from the region MSMEG_5999 to
MSMEG_6017 and were associated with the motif iden-
tified (Fig. 1).
In order to propose a regulon for kstR2, we have combined
the microarray data with bioinformatic analysis and have
taken motif location, genomic arrangement (the likely
operon structure deduced from gene direction and the
distances between genes), gene conservation and de-
repression by cholesterol in R. jostii into account. The
kstR2 regulon is defined below.
Fig. 1. The putative kstR2 regulon in M. smegmatis. (a) Representation of the M. smegmatis genome from MSMEG_5893 to
MSMEG_6043. The directions of the arrows represent gene direction and the arrows filled in black are genes controlled by
kstR (Kendall et al., 2007). (b) The magnified region corresponds to MSMEG_5999 to MSMEG_6017 and the bottom two lines
of arrows correspond to the M. tuberculosis and R. jostii RHA1 genomes. Orthologous genes are indicated by the grey shaded
areas. Although MSMEG_6010 and Rv3558 have a conserved context (neighbouring genes are conserved) there is no
homology between these two genes and they are not considered to be orthologues. The locations of the KstR2 motif are
indicated by asterisks and the sizes of the intergenic regions in the M. smegmatis genome are shown. Genes indicated by
thickly outlined arrows in the rhodococcal genome have been shown previously to be induced by cholesterol (Van der Geize
et al., 2007). Genes indicated by arrows filled in black in the M. smegmatis genome are those in the kstR2 regulon.
Fig. 2. Sequence logo of the KstR2 binding
motif. Sequence logos (Crooks et al., 2004)
show the relative frequency of each base at
each position of the motif. The y-axis shows
the information content.
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The microarray analysis shows that MSMEG_5999 to
MSMEG_6004 are highly de-repressed in the mutant
(Table 4). There are no intergenic gaps in the run of genes
MSMEG_6001 to MSMEG_6004 and only a 14 bp gap
upstream of MSMEG_5999 (Fig. 1), suggesting that
MSMEG_6001 to MSMEG_6004 and MSMEG_6000 to
MSMEG_5999 are transcribed in two divergent operons. A
motif is present in the 60 bp intergenic region between
MSMEG_6000 and MSMEG_6001, and the orthologous
genes are de-repressed in R. jostii by cholesterol (Fig. 1).
This, together with the demonstration that KstR2Mtb binds
to the motif located between the orthologous M.
tuberculosis genes (Fig. 3a), strongly suggests that KstR2
divergently represses these genes and that this repression is
alleviated by cholesterol.
The results suggest that MSMEG_6005, MSMEG_6006 and
MSMEG_6007 are not regulated by KstR2. Firstly, the
microarray analysis shows that these genes are not highly
or significantly de-repressed in the mutant (Table 4).
Secondly, these genes are not conserved in R. jostii (or M.
tuberculosis) so they are unlikely to be required for
cholesterol degradation (Fig. 1). There is a 42 bp intergenic
region upstream of MSMEG_6005 and an 87 bp intergenic
region upstream of MSMEG_6007, which would allow for
the presence of an independent promoter, but there is no
associated kstR2 motif (Fig. 1). Taken together, the data
suggest that these genes are not under the control of KstR2.
The microarray data show kstR2 (MSMEG_6009) as being
downregulated in the mutant strain because this gene is
deleted in the mutant. The gene downstream of kstR2,
MSMEG_6008, however, is highly and significantly de-
repressed in the mutant strain (Table 4) and there is no
intergenic gap between kstR2 and MSMEG_6008, suggest-
ing they are co-transcribed. There is a motif in the 303 bp
gap upstream of kstR2 to which KstR2 binds (Fig. 3a) and
the orthologues of both genes are de-repressed by
cholesterol in R. jostii (Fig. 1). This suggests that kstR2
and MSMEG_6009 are expressed as an operon under the
control of KstR2.
The run of genes MSMEG_6011 to MSMEG_6017 appear
to be arranged into two divergent operons: MSMEG_6012
to MSMEG_6011 and MSMEG_6013 to MSMEG_6017
(Fig. 1). There is a motif in the 104 bp intergenic region
between MSMEG_6012 and MSMEG_6013 to which KstR2
binds (Fig. 3a). Microarray analysis suggests that these
genes are de-repressed in the mutant (Table 4). Levels
were not high or significant for MSMEG_6013 and
MSMEG_6014 in this microarray experiment, but de-
repression was confirmed by RTq-PCR (data not shown).
Table 3. Instances of the KstR2 motif in M. smegmatis, M. tuberculosis and R. jostii
ND, Not done; +, positive EMSA result. Underlining represents the motif location.
Motif sequence P-value Flanking genes EMSA
M. smegmatis
TACCAAGCAAGTGCTTGCTTAGGT 2.0e208 MSMEG_6000/MSMEG_6001 ND
TACCAACCAAGCACTTGCTAGGTC 5.6e214 MSMEG_6009/MSMEG_6010 ND
AACCTACCAAGCACTTGCTTTGTT 3.6e208 MSMEG_6012/MSMEG_6013 ND
M. tuberculosis
TACCAAGCAAGTGCTTGCTTAGGT 2.0e208 Rv3549c/Rv3550 +
TATCAACCAAGCGCTTGCTCGGCC 2.0e215 Rv3557c/Rv3558 +
AACCTACCAAGCACTTGCTTTGTT 3.6e208 Rv3560c/Rv3561 +
R. jostii
ACCGAACCAAGCGATTGCTTGGTA 1.9e207 ro04652/04653 ND
GCCCTAACAAGCGCTTGGTTGATA 7.0e214 ro04598 ND
TACCTAGCAAGTGCTTGGTAGGTT 3.9e207 ro04595/04596 ND
Fig. 3. Binding of purified KstR2Mtb to 30 bp probes containing
the motif. (a) EMSA of purified KstR2Mtb to 30 bp probes from the
three intergenic regions (Rv3549c–Rv3550, Rv3557c–Rv3558
and Rv3560c–Rv3561). Lanes: 1, Rv3549c–Rv3550;2 ,
Rv3557c–Rv3558;3 ,Rv3560c–Rv3561. +, with protein; ”,
without protein. (b) Specific binding of purified KstR2Mtb to a
30 bp probe from the Rv3557c–Rv3558 intergenic region. Lanes:
1, labelled probe with protein; 2, labelled probe with protein and
with 150-fold excess unlabelled probe; 3, labelled probe with
protein and with an excess of poly[d(I-C)].
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which there is no rhodococcal orthologue) are de-repressed
by cholesterol in R. jostii. Taken together, the data suggest
that KstR2 binds to the motif in the intergenic region
between MSMEG_6012 and MSMEG_6013 to divergently
repress expression and that repression is alleviated by
cholesterol.
Finally, the microarray analysis suggests that MSMEG_6010
is not de-repressed in the mutant strain (Table 4) and we
have used RTq-PCR to confirm this result (data not shown).
There is no orthologue in M. tuberculosis or R. jostii so this
gene is unlikely to be required for cholesterol degradation
(Fig. 1). This suggests that KstR2 binds to the motif within
the intergenic region between kstR2 and MSMEG_6010
to cause repression in one direction only. This is in contrast
with the other promoter regions where both divergently
located genes are repressed by binding of KstR2 to the
motif. Consistent with this, the distance between the
putative start of MSMEG_6010 and the kstR2 motif is large
(285 bp) in comparison with the rest of the motif to
start site distances (MSMEG_6000,2 2b p ;MSMEG_6001,
39 bp; MSMEG_6009, 22 bp; MSMEG_6012, 23 bp; and
MSMEG_6013, 82 bp). Additionally, a recent study has
shown that in M. tuberculosis kstR2 and Rv3556c are
de-repressed by cholesterol but Rv3558c (PPE64) is not
(Nesbitt et al., 2010).
In addition to the genes within the MSMEG_5999 to
MSMEG_6017 region, three genes were significantly down-
regulated (Table 4). However, none of these genes was
associated with a motif and downregulation is likely to be
due to secondary effects of the kstR2 deletion rather than
direct control. In summary, the data show that KstR2
controls the expression of 15 genes within the
MSMEG_5999 to MSMEG_6017 region. These genes are
in black in Fig. 1 and in bold type in Table 4.
KstR2 and KstR act independently of each other
In order to test whether there is any interaction between
the two regulators, we decided to measure the expression of
KstR- and KstR2-controlled genes in a wild-type, DkstR2
and DkstR/DkstR2 double mutant background of M.
Table 4. Expression analysis of DkstR2Msm and the kstR2 regulon
Genes in bold type are part of the kstR2 regulon.
Direction of
transcription
M. smegmatis gene Fold change P-value M. tuberculosis gene Function
MSMEG_1061 genes 240.4 5.0e203 – Phosphohydrolase
MSMEG_1112 245.2 2.0e202 – Putative aconitase hydratase
q MSMEG_5999* 140.3 1.0e”04 Rv3548c Probable short-chain-type dehydrogenase/reductase
q MSMEG_6000* 2017.0 1.2e”07 Rv3549c Probable short-chain-type dehydrogenase/reductase
Q MSMEG_6001* 250.7 2.0e”05 Rv3550 Probable enoyl-CoA hydratase
Q MSMEG_6002* 150.5 7.0e”05 Rv3551Dd§ Possible CoA-transferase (alpha subunit)
Q MSMEG_6003* 110.6 8.2e”05 Rv3552D§ Possible CoA-transferase (beta subunit)
Q MSMEG_6004* 5.2 1.9e”01 Rv3553 Possible oxidoreductase
Q MSMEG_6005 2.3 5.5e201 – Hypothetical protein
Q MSMEG_6006 1.1 9.6e201 – Hypothetical protein
q MSMEG_6007 21.1 9.6e201 – Cation diffusion transporter||
q MSMEG_6008* 88.8 8.2e”05 Rv3556cDd§ Probable acetyl-CoA acetyltransferase
q MSMEG_6009* ”1.2 9.0e”01 Rv3557c§ Transcriptional regulatory protein (kstR2)
Q MSMEG_6010 23.0 3.0e201 – Hypothetical protein
q MSMEG_6011* 3.2 3.4e”01 Rv3559c Possible oxidoreductase
q MSMEG_6012* 173.6 2.0e”05 Rv3560cDd Probable acyl-CoA dehydrogenase
Q MSMEG_6013* 2.2 5.1e”01 Rv3561§ Probable fatty-acid-CoA ligase||
Q MSMEG_6014* 1.6 7.6e”01 Rv3562§ Probable acyl-CoA dehydrogenase
Q MSMEG_6015* 15.5 2.6e”02 Rv3563Dd Probable acyl-CoA dehydrogenase
Q MSMEG_6016* 9.5 9.4e”02 Rv3564 Probable acyl-CoA dehydrogenase
Q MSMEG_6017* 100.8 9.5e”01 Rv3565 Possible aspartate aminotransferase
MSMEG_6197 215.9 4.0e202 – Diaminopimelate decarboxylase
*Orthologous genes de-repressed by cholesterol in Rhodococcus jostii RHA1.
DEssential in macrophages according to transposon site hybridization (TraSH) studies (Rengarajan et al., 2005).
dEssential in mice according to TraSH studies (Sassetti & Rubin, 2003).
§Induced in macrophages (Schnappinger et al., 2003).
||M. smegmatis gene contains a frameshift mutation – pseudogene?
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1368 Microbiology 156smegmatis using RTq-PCR. The DkstR/DkstR2 mutant was
made by deleting kstR2 in a DkstRMsm mutant that has
been described previously (Kendall et al., 2007). We
chose to focus on MSMEG_6001 (KstR2-regulated) and
MSMEG_6038 (KstR-regulated), because they were highly
de-repressed in their respective mutant backgrounds (see
Table 4 and Kendall et al., 2007) and would therefore act as
good reporters. The results, which are given in Fig. 4, show
that (as expected) both genes are repressed in the wild-type
strain mc
2155. The kstR2-regulated gene MSMEG_6001
is de-repressed in the DkstR2Msm mutant but the level of
de-repression does not increase when kstR is also absent.
Additionally, knocking out kstR2 has no effect on the
expression levels of MSMEG_6038,akstR-regulated gene.
These results clearly show that there is no cross-talk
between the regulators.
DISCUSSION
Previous studies have identified a TetR repressor, kstR, that
controls a number of genes that are de-repressed by growth
on cholesterol (Kendall et al., 2007; Van der Geize et al.,
2007). In this study, we show that a second TetR-type
repressor, kstR2, controls the expression of a small regulon
that may also play a role in the utilization of cholesterol in
mycobacteria. This second regulon, which consists of 15
genes, is located in the same region as the kstR regulon and
is de-repressed in R. jostii by growth in cholesterol (Fig. 1
and Table 4). The expression of the genes in the kstR2
regulon is not affected by a deletion in kstR; therefore the
two regulators act independently of each other. Both KstR
and KstR2 negatively autoregulate themselves. This is a
common feature of gene regulation and occurs in over
40% of the transcription factors in E. coli (Shen-Orr et al.,
2002). Negative autoregulation is known to speed up
response time, reduce stochastic gene expression noise and
be metabolically economical for the cell (Nevozhay et al.,
2009).
The precise roles of each of the genes in the kstR or kstR2
regulons in cholesterol catabolism have yet to be fully
defined. Although it is clear that both regulons are de-
repressed by cholesterol, not all of the genes may be
involved in the degradative pathway. KstR and KstR2 co-
ordinately control over 70 genes that are all de-repressed by
growth on cholesterol. Van der Geize et al. (2007) assigned
28 mycobacterial genes (27 of which belong to the kstR
regulon) to cholesterol degradation based on sequence
identity with other steroid-degrading species. However,
only three of the M. tuberculosis enzymes have been
demonstrated biochemically to catalyse steps in the
degradation pathway. This means that the precise functions
of many of the genes in both regulons remain undefined. It
is possible that the genes may be involved in the
assimilation of the products of cholesterol degradation.
Cholesterol catabolism generates propionyl-CoA which has
been shown to be incorporated into complex methyl-
branched chain fatty acids found in the mycobacterial cell
wall (Yang et al., 2009). Therefore, it is possible that some
of the genes in the kstR and kstR2 regulons are involved in
these synthetic pathways. The observation that arylamine
N-acetyltransferase in M. tuberculosis (TBNAT), one of the
genes in the kstR regulon in M. tuberculosis (although not
in M. smegmatis), is able to utilize propionyl-CoA provides
evidence for this (Lack et al., 2009).
Recent in vivo studies in M. tuberculosis provide contra-
dictory information about the temporal requirement for
Fig. 4. Expression levels of MSMEG_6001
and MSMEG_6038 in a wild-type, DkstR2Msm
mutant and DkstR/DkstR2Msm mutant back-
ground. The expression levels were measured
in mid-exponential-phase aerated cultures
using RTq-PCR as described in Methods.
The results are expressed relative to sigA
which was not significantly different (unpaired
Student’s t-test; P.0.05) in the mutants
compared with the wild-type. Levels of sigA
expression for the wild-type, DkstR2Msm and
DkstR/DkstR2Msm were 90495 (±10458),
89635 (±4929) and 75180 (±3818) copies
(ml cDNA)
”1, respectively. Significantly upreg-
ulated (de-repressed) genes in the mutants
compared with the wild-type are marked with
asterisks (unpaired Student’s t-test; P,0.05).
Error bars represent ±1 SD. Black bars,
MSMEG_6001 (a KstR2-regulated gene);
white bars, MSMEG_6038 (a KstR-regulated
gene).
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DkshA and DkshB mutants (which are all kstR-regulated
genes) are attenuated in the early stages of infection
(Chang et al., 2009; Hu et al., 2010; Yam et al., 2009).
However, deletion of the cholesterol importer (mce4) and
another kstR-regulated gene, fadA5, results in attenuation
in the persistent stage of infection (Nesbitt et al., 2010;
Pandey & Sassetti, 2008). Studies in vitro have shown that
the propionyl-CoA generated from cholesterol catabolism
only becomes a significant source of propionate in the
absence of sugar carbon sources (Yang et al., 2009).
Therefore, it is possible that, although the potential to
metabolize cholesterol is present throughout infection, the
contribution to bacterial metabolism only becomes sig-
nificant in the later stages of infection when sugar sources
of carbon may have run out. The fact that the cholesterol
catabolism genes are controlled by two transcriptional
regulators may have implications for the temporal
expression of each of the regulons during infection.
The degradation of cholesterol and the subsequent
elevation of propionyl-CoA levels is a double-edged sword.
While propionyl-CoA is a useful metabolite, particularly
for the biosynthesis of cell wall fatty acids, accumulation of
propionate is also toxic. The accumulation of toxic
metabolites has been suggested to be the cause of the early
attenuation seen in some of the mutants mentioned above
(Chang et al., 2009; Yam et al., 2009). However, it is
thought not to account for the early attenuation seen in the
DkshA and DkshB mutants, as the addition of cholesterol to
these mutants growing in glucose does not result in
inhibition (Hu et al., 2010). The addition of cholesterol to
wild-type cultures grown in glucose also does not result in
growth inhibition. In this case, we would expect de-
repression of the genes in the kstR and kstR2 regulons
enabling the wild-type bacteria to fully metabolize
cholesterol. Similarly, the DkstR and DkstR2 mutants are
able to fully metabolize cholesterol as the genes in the
regulons are constitutively de-repressed.
Sequencing of the M. tuberculosis genome revealed
approximately 250 genes involved in lipid metabolism
but the precise metabolic pathways in which these genes
function have yet to be dissected (Camus et al., 2002; Cole,
1999). Identifying regulons (i.e. subsets of genes that are
co-regulated) helps to assign genes to specific metabolic
pathways. The work presented here on kstR2 and our
previous studies with kstR have identified two regulons,
and other laboratories have shown that these genes are
de-repressed by growth on cholesterol. The observation
that there are (at least) two independently acting regulators
involved in cholesterol catabolism invites a number of
interesting questions regarding the role of each regulator in
pathogenesis. Are the regulons switched on in response to
cholesterol simultaneously? Do the regulators recognize
and bind to the same ligand? Is there biological significance
in this dual regulation or is it just a remnant of how this
pathway evolved? Further experiments are required to
answer these questions.
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